These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 37251813)
1. Comparison of allergen immunotherapy practice patterns in inhalant allergies in the United States of America and Europe: Similarities and differences 2023. Pfaar O; Becker S; Calabria C; Hartenstein D; Jung J; Zimmer J; Ponda P World Allergy Organ J; 2023 May; 16(5):100766. PubMed ID: 37251813 [TBL] [Abstract][Full Text] [Related]
3. State of the Art: Development of a Sublingual Allergy Immunotherapy Tablet for Allergic Rhinitis in Japan. Ohashi-Doi K; Lund K; Mitobe Y; Okamiya K Biol Pharm Bull; 2020; 43(1):41-48. PubMed ID: 31902930 [TBL] [Abstract][Full Text] [Related]
4. Recent developments and highlights in allergen immunotherapy. Pfaar O; Lou H; Zhang Y; Klimek L; Zhang L Allergy; 2018 Dec; 73(12):2274-2289. PubMed ID: 30372537 [TBL] [Abstract][Full Text] [Related]
5. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Pfaar O; Demoly P; Gerth van Wijk R; Bonini S; Bousquet J; Canonica GW; Durham SR; Jacobsen L; Malling HJ; Mösges R; Papadopoulos NG; Rak S; Rodriguez del Rio P; Valovirta E; Wahn U; Calderon MA; Allergy; 2014 Jul; 69(7):854-67. PubMed ID: 24761804 [TBL] [Abstract][Full Text] [Related]
6. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies. Calderon MA; Casale TB; Nelson HS; Demoly P J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829 [TBL] [Abstract][Full Text] [Related]
7. SQ house dust mite sublingual immunotherapy for the treatment of adults with house dust mite-induced allergic rhinitis. Meteran H; Backer V Expert Rev Clin Immunol; 2019 Nov; 15(11):1127-1133. PubMed ID: 31584839 [No Abstract] [Full Text] [Related]
8. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma. Hesse L; Petersen AH; Nawijn MC Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602 [TBL] [Abstract][Full Text] [Related]
9. New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ Vitiello G; Maltagliati L; Rossi O Clin Mol Allergy; 2020; 18():10. PubMed ID: 32536827 [TBL] [Abstract][Full Text] [Related]
10. Allergen Immunotherapy in Asthma. Nakagome K; Nagata M Pathogens; 2021 Oct; 10(11):. PubMed ID: 34832562 [TBL] [Abstract][Full Text] [Related]
11. House dust mite subcutaneous immunotherapy in Chinese patients with allergic asthma and rhinitis. Feng M; Zeng X; Li J J Thorac Dis; 2019 Aug; 11(8):3616-3625. PubMed ID: 31559069 [TBL] [Abstract][Full Text] [Related]
12. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma. Hesse L; Nawijn MC Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043 [TBL] [Abstract][Full Text] [Related]
13. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial. Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432 [TBL] [Abstract][Full Text] [Related]
15. Principles of Allergen Immunotherapy and Its Clinical Application in China: Contrasts and Comparisons with the USA. Guan K; Liu B; Wang M; Li Z; Chang C; Cui L; Wang RQ; Wen LP; Leung PSC; Wei JF; Sun JL Clin Rev Allergy Immunol; 2019 Aug; 57(1):128-143. PubMed ID: 31243705 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy in the Treatment of Allergic Rhinitis in Children. Alamri RA; Aljabri GH; Tahlawi R; Aljabri HA Cureus; 2022 Dec; 14(12):e32464. PubMed ID: 36644088 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial. Nolte H; Bernstein DI; Nelson HS; Kleine-Tebbe J; Sussman GL; Seitzberg D; Rehm D; Kaur A; Li Z; Lu S J Allergy Clin Immunol; 2016 Dec; 138(6):1631-1638. PubMed ID: 27521719 [TBL] [Abstract][Full Text] [Related]
18. Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma. Vogelberg C; Brüggenjürgen B; Richter H; Jutel M Patient Prefer Adherence; 2020; 14():817-827. PubMed ID: 32494127 [TBL] [Abstract][Full Text] [Related]
19. [Immunotherapy of allergies: current status]. Mahler V; Kleine-Tebbe J; Vieths S Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Nov; 63(11):1341-1356. PubMed ID: 33140209 [TBL] [Abstract][Full Text] [Related]
20. The Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) survey: patients' experience with allergen immunotherapy. Skoner DP; Blaiss MS; Dykewicz MS; Smith N; Leatherman B; Bielory L; Walstein N; Craig TJ; Allen-Ramey F Allergy Asthma Proc; 2014; 35(3):219-26. PubMed ID: 24801464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]